Profitability of Large Pharmaceutical Companies Compared With Other Large Public Companies
Open Access
- 3 March 2020
- journal article
- research article
- Published by American Medical Association (AMA) in Jama-Journal Of The American Medical Association
- Vol. 323 (9), 834-843
- https://doi.org/10.1001/jama.2020.0442
Abstract
Policy makers face growing pressure to reduce the cost of drugs in the United States.1-6 This pressure arises from concern that essential drugs are increasingly unaffordable and that excessive pharmaceutical company profits contribute to high drug prices.1,5,7-11Keywords
This publication has 7 references indexed in Scilit:
- Lowering Cost and Increasing Access to Drugs Without Jeopardizing InnovationJama-Journal Of The American Medical Association, 2019
- Prescription Drugs—List Price, Net Price, and the Rebate Caught in the MiddleJama-Journal Of The American Medical Association, 2019
- The High Cost of Prescription Drugs in the United StatesJama-Journal Of The American Medical Association, 2016
- An overview of FDA-approved new molecular entities: 1827–2013Drug Discovery Today, 2014
- Quantile RegressionPublished by Cambridge University Press (CUP) ,2005
- How Much Should We Trust Differences-In-Differences Estimates?The Quarterly Journal of Economics, 2004
- The Pharmaceutical Industry — To Whom is It Accountable?New England Journal of Medicine, 2000